Medical weight loss is clinician-supervised treatment that can include GLP-1 medicines such as semaglutide or tirzepatide along with diet and activity changes.
Lower obesity, not lower diabetes
San Jose's adult obesity rate is 23.7% in CDC estimates, lower than many large cities, yet 11.1% of adults have diagnosed diabetes [4]. Santa Clara County figures are 21.9% and 10.5% [6]. Obesity rates alone do not capture metabolic risk, so a prescriber looks at blood sugar, blood pressure and history, not BMI only.
Sponsored placement: open.
One local practice can be featured here. This is a paid, labeled placement and never an endorsement.
Feature your practice in San Jose, from $300 a month.
This is a paid, labeled listing. Sponsorship does not influence our editorial pages.
Semaglutide or tirzepatide
In SURMOUNT-5, a head-to-head trial, adults with obesity lost an average of 20.2% of body weight on tirzepatide and 13.7% on semaglutide at 72 weeks [7]. Semaglutide is sold as Wegovy (pen or pill) for weight [8]; tirzepatide as Zepbound [9]. Read Wegovy vs Zepbound, semaglutide and tirzepatide.
| Drug | Brand and form | Per month | Source |
|---|---|---|---|
| Semaglutide | Wegovy pill | $149 to $299 | [1] |
| Semaglutide | Wegovy pen | $349 | [1] |
| Tirzepatide | Zepbound, 2.5 mg and 5 mg | $299 and $399 | [2] |
| Tirzepatide | Zepbound, 7.5 to 15 mg (on-time refill) | $449 | [2] |
Insurance in a high-income city
San Jose's median household income, $146,427, is among the highest of the cities we cover [5]. Many residents have employer plans, but Lilly, citing an IFEBP survey, says about half of people with employer insurance lack coverage for obesity drugs [10]. If your plan covers Zepbound, the savings card can cut the cost to as little as $25 [11]; Wegovy's offer for covered patients is as little as $25 a month [1]. Medi-Cal still covers members under 21 [3]. More in insurance and Medicare coverage.
Where to get care
Stanford Health Care serves Santa Clara County; we did not confirm a weight program price there. Prescribers should be licensed by the Medical Board of California [12]. Neither compounded semaglutide nor compounded tirzepatide is FDA-approved, and FDA does not review either for safety, effectiveness or quality [13]. Use the clinic checklist. Nearby: San Francisco, Sacramento and Los Angeles.
Label safety
Both drugs list pancreatitis; get care for severe stomach pain that will not go away [8] [14]. Low blood sugar is more likely if you also use insulin or a sulfonylurea. Facial swelling or trouble breathing calls for urgent help. Each carries a boxed warning about thyroid C-cell tumors and should not be used with a personal or family history of medullary thyroid carcinoma or MEN 2. Stop when pregnancy is recognized. Call 911 for emergencies.
Questions people ask
How much is semaglutide in San Jose?
Wegovy, the semaglutide brand for weight, costs $149 to $299 a month as a pill and $349 as a pen through NovoCare self-pay, checked Oct 17, 2026 [1].
How much is tirzepatide in San Jose?
Zepbound on LillyDirect costs $299 for 2.5 mg, $399 for 5 mg and $449 for 7.5 to 15 mg when refilled within 45 days, checked Oct 17, 2026 [2].
Does Medi-Cal cover Wegovy or Zepbound?
Not for adult weight loss since January 1, 2026. Members under 21 remain covered [3].
What is the obesity rate in San Jose?
CDC PLACES estimates 23.7% of San Jose adults had obesity and 11.1% had diagnosed diabetes in 2023 [4].
Which works better, semaglutide or tirzepatide?
Head to head in SURMOUNT-5, people on tirzepatide lost 20.2% of body weight on average at 72 weeks, compared with 13.7% on semaglutide. Results differ by person [7].
Sources
14 cited
- Wegovy self-pay offer, NovoCare Pharmacy. Novo Nordisk (NovoCare), Oct 17, 2026.
- Zepbound self-pay prices on LillyDirect. Eli Lilly and Company (LillyDirect), Oct 17, 2026.
- California Medicaid ends coverage of GLP-1 drugs for weight loss. KFF Health News, Jan 9, 2026.
- PLACES data, place, 2025 release: San Jose, CA. Centers for Disease Control and Prevention, 2025 release (2023 BRFSS).
- QuickFacts: San Jose city, California. U.S. Census Bureau, 2025 estimates and 2020-2024 ACS; accessed 2026-10-17.
- PLACES data, county, 2025 release: Santa Clara County, CA. Centers for Disease Control and Prevention, 2025 release (2023 BRFSS).
- Tirzepatide as compared with semaglutide for the treatment of obesity (SURMOUNT-5). New England Journal of Medicine (PubMed), 2025.
- Wegovy label (injection and tablets). DailyMed, National Library of Medicine, Jun 2026.
- Zepbound label. DailyMed, National Library of Medicine, Aug 2026.
- Foundayo now available (Lilly press release citing IFEBP survey). Eli Lilly and Company, Apr 9, 2026.
- Zepbound coverage and savings. Eli Lilly and Company, Oct 17, 2026.
- Medical Board of California. State of California, accessed 2026-10-17.
- FDA's concerns with unapproved GLP-1 drugs used for weight loss. U.S. Food and Drug Administration, Oct 1, 2026.
- Zepbound (tirzepatide) prescribing information. U.S. Food and Drug Administration, Apr 2026.
This page is general information, not medical advice. Talk with a licensed clinician about your own care.